CHGCF vs ABBV: Which Stock is Better?
Side-by-side comparison of Chugai Pharmaceutical Co. Ltd and Abbvie Inc in 2026
CHGCF
Chugai Pharmaceutical Co. Ltd
$60.19
ABBV
Abbvie Inc
$208.38
Key Metrics Comparison
| Metric | CHGCF | ABBV | Winner |
|---|---|---|---|
| Market Cap | $99.06B | $368.57B | ABBV |
| P/E Ratio | 36.04 | 87.55 | CHGCF |
| EPS (TTM) | $1.67 | $2.38 | ABBV |
| Revenue Growth | 0.1% | 0.1% | CHGCF |
| Gross Margin | 71.1% | 71.6% | ABBV |
Analyze CHGCF
Full quant analysis
Analyze ABBV
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CHGCF or ABBV a better investment?
Comparing CHGCF and ABBV: Chugai Pharmaceutical Co. Ltd has a market cap of $99.06B while Abbvie Inc has $368.57B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CHGCF and ABBV?
CHGCF (Chugai Pharmaceutical Co. Ltd) and ABBV (Abbvie Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CHGCF or ABBV?
Based on P/E ratios, CHGCF trades at a lower multiple (36.0x vs 87.6x).
Which is growing faster: CHGCF or ABBV?
CHGCF has higher revenue growth at 0.1% vs 0.1% for ABBV.
Which company is more profitable: CHGCF or ABBV?
Abbvie Inc (ABBV) has higher gross margins at 71.6% compared to 71.1% for CHGCF.
Which is the larger company: CHGCF or ABBV?
Abbvie Inc (ABBV) is larger with a market cap of $368.57B compared to $99.06B for CHGCF.
Should I buy CHGCF or ABBV in 2026?
Both CHGCF and ABBV have investment merit. CHGCF trades at $60.19 while ABBV trades at $208.38. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CHGCF and ABBV stock?
Key differences: Market Cap ($99.06B vs $368.57B), P/E Ratio (36.0x vs 87.6x), Revenue Growth (0.1% vs 0.1%), Gross Margin (71.1% vs 71.6%).